Alyeska Investment Group
PETX

Alyeska Investment Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Alyeska Investment Group’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-137,345
Closed -$584K – 569
2018
Q2 		$584K Buy
+137,345
New +$692K 0.01% 419
2017
Q4 		– Sell
-964,116
Closed -$5.91M – 574
2017
Q3 		$5.91M Buy
964,116
+91,763
+11% +$581K 0.04% 281
2017
Q2 		$6.31M Buy
872,353
+722,353
+482% +$4.44M 0.05% 270
2017
Q1 		$795K Buy
+150,000
New +$1.01M 0.01% 441
2016
Q3 		– Sell
-1,508,548
Closed -$9.53M – 559
2016
Q2 		$9.53M Buy
1,508,548
+258,548
+21% +$1.66M 0.09% 258
2016
Q1 		$6.9M Buy
1,250,000
+564,448
+82% +$2.12M 0.06% 266
2015
Q4 		$3.83M Buy
685,552
+123,873
+22% +$819K 0.04% 273
2015
Q3 		$4.75M Buy
561,679
+418,427
+292% +$7.08M 0.06% 255
2015
Q2 		$2.17M Buy
143,252
+80,712
+129% +$1.17M 0.02% 341
2015
Q1 		$1M Sell
62,540
-18,564
-23% -$330K 0.01% 433
2014
Q4 		$1.45M Sell
81,104
-24,396
-23% -$304K 0.02% 364
2014
Q3 		$1.06M Buy
105,500
+73,483
+230% +$891K 0.02% 321
2014
Q2 		$500K Sell
32,017
-48,876
-60% -$693K 0.01% 379
2014
Q1 		$1.5M Buy
+80,893
New +$1.62M 0.04% 276

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 42.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Alyeska Investment Group's PETX Position: Q3 2018 in Review

Alyeska Investment Group sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2018, closing a stake of 137,345 shares — an estimated $584K sold.

Alyeska Investment Group first reported a position in PETX in Q1 2014 and held it in 14 quarters. The position peaked at $9.53M in Q2 2016. 100 funds tracked by Wall St. Rank hold PETX as of Q3 2018.

  • Alyeska Investment Group reported no remaining Aratana Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 137,345 Aratana Therapeutics, Inc. shares in Q3 2018, an estimated $584K.
  • Alyeska Investment Group first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 14 quarters.
  • Alyeska Investment Group's Aratana Therapeutics, Inc. position peaked at $9.53M in Q2 2016.
  • 100 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2018.

Based on Alyeska Investment Group's 13F filing for Q3 2018, filed 14 Nov 2018.